[1]
A. S. Ainaputri, “Butirat Supplementation and Epigenetic Modulation via Histon Deacetylase Inhibition in Type 2 Diabetes: A Narrative Review with Perspectives for Indonesia”, JPS, vol. 9, no. 1, pp. 407–422, Feb. 2026.